A kit for assisting in judging the recurrence risk of endometrial cancer
A technology of endometrial cancer and a kit, applied in the field of biomedicine, can solve the problems that the prognosis model has not yet been initially established, and endometrial cancer is in its initial stage.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0160] The experimental methods used in the following examples are conventional methods unless otherwise specified.
[0161] The materials and reagents used in the following examples can be obtained from commercial sources unless otherwise specified.
[0162] 1. Screening of independent risk factors for endometrial cancer recurrence
[0163] By analyzing the information of 520 endometrial cancer patients with complete clinical pathological data in the first hand pathological staging operation at Peking University People’s Hospital from January 2006 to December 2016. Collect the patient's preoperative age, lesion size, postoperative pathological type, stage, differentiation, whether the ascites tumor cells are positive, and lymphatic vessel tumor thrombus.
[0164] After the completion of systemic treatment, all patients were followed up by outpatient clinic, inpatient follow-up and telephone follow-up. Patients were followed up every 3 months in the first 1-2 years, every 6 months in ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com